Search research articles
Contact Us
Filters
Showing results (21-30 of 33) with videos related to
Page
of 4
Sort By:
Journal of Cancer Research and Clinical Oncology
|
November 19, 2018
Calpain system protein expression and activity in ovarian cancer
Siwei Zhang, Suha Deen, Sarah J Storr, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 17, 2008
Vascular endothelial growth factor expression in ovarian cancer: a model for targeted use of novel therapies?
Timothy J Duncan, Ahmad Al-Attar, Phil Rolland, et al.
Gynecologic Oncology
|
November 5, 2013
Preventing endometrial cancer risk in polycystic ovarian syndrome (PCOS) women: could metformin help?
Mohamad Nasir Shafiee, Gulafshana Khan, Rina Ariffin, et al.
Oncotarget
|
December 20, 2017
High mobility group protein B1 is a predictor of poor survival in ovarian cancer
Lee R Machado, Paul M Moseley, Robert Moss, et al.
The American Journal of Surgical Pathology
|
October 18, 2012
Clinical outcome of atypical endometrial hyperplasia diagnosed on an endometrial biopsy: institutional experience and review of literature
Emad Rakha, Siew Chee Wong, Irshad Soomro, et al.
Genome Biology
|
January 23, 2015
Combined image and genomic analysis of high-grade serous ovarian cancer reveals PTEN loss as a common driver event and prognostic classifier
Filipe C Martins, Ines de Santiago, Anne Trinh, et al.
Histochemistry and Cell Biology
|
May 18, 2026
DHX37 protein and mRNA expression patterns in breast and ovarian cancer and their prognostic implications
Denys Ndeke, Sandra Sam, Nuanphan Polchai, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
July 30, 2020
Refined cut-off for TP53 immunohistochemistry improves prediction of TP53 mutation status in ovarian mucinous tumors: implications for outcome analyses
Eun Young Kang, Dane Cheasley, Cecile LePage, et al.
The Lancet. Oncology
|
July 13, 2013
Hormone-receptor expression and ovarian cancer survival: an Ovarian Tumor Tissue Analysis consortium study
Weiva Sieh, Martin Köbel, Teri A Longacre, et al.
Mayo Clinic Proceedings
|
March 6, 2018
MyD88 and TLR4 Expression in Epithelial Ovarian Cancer
Matthew S Block, Robert A Vierkant, Peter F Rambau, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 33) with videos related to
Sort By:
Page
of 4
Journal of Cancer Research and Clinical Oncology
|
November 19, 2018
Calpain system protein expression and activity in ovarian cancer
Siwei Zhang, Suha Deen, Sarah J Storr, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 17, 2008
Vascular endothelial growth factor expression in ovarian cancer: a model for targeted use of novel therapies?
Timothy J Duncan, Ahmad Al-Attar, Phil Rolland, et al.
Gynecologic Oncology
|
November 5, 2013
Preventing endometrial cancer risk in polycystic ovarian syndrome (PCOS) women: could metformin help?
Mohamad Nasir Shafiee, Gulafshana Khan, Rina Ariffin, et al.
Oncotarget
|
December 20, 2017
High mobility group protein B1 is a predictor of poor survival in ovarian cancer
Lee R Machado, Paul M Moseley, Robert Moss, et al.
The American Journal of Surgical Pathology
|
October 18, 2012
Clinical outcome of atypical endometrial hyperplasia diagnosed on an endometrial biopsy: institutional experience and review of literature
Emad Rakha, Siew Chee Wong, Irshad Soomro, et al.
Genome Biology
|
January 23, 2015
Combined image and genomic analysis of high-grade serous ovarian cancer reveals PTEN loss as a common driver event and prognostic classifier
Filipe C Martins, Ines de Santiago, Anne Trinh, et al.
Histochemistry and Cell Biology
|
May 18, 2026
DHX37 protein and mRNA expression patterns in breast and ovarian cancer and their prognostic implications
Denys Ndeke, Sandra Sam, Nuanphan Polchai, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
July 30, 2020
Refined cut-off for TP53 immunohistochemistry improves prediction of TP53 mutation status in ovarian mucinous tumors: implications for outcome analyses
Eun Young Kang, Dane Cheasley, Cecile LePage, et al.
The Lancet. Oncology
|
July 13, 2013
Hormone-receptor expression and ovarian cancer survival: an Ovarian Tumor Tissue Analysis consortium study
Weiva Sieh, Martin Köbel, Teri A Longacre, et al.
Mayo Clinic Proceedings
|
March 6, 2018
MyD88 and TLR4 Expression in Epithelial Ovarian Cancer
Matthew S Block, Robert A Vierkant, Peter F Rambau, et al.
Page
of 4